Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 126

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 126
---
 owned patents and patent
applications below are directed toward various aspects of our family of products, methods of their manufacturing, delivery device and
research programs.

| Effective     
 Filing Date   |     | Patent No.   |     | Title                                                                                                                                  |     | Country                                       |     | Product     |     | Type of patent protection |     | Expiry date   |
| Dec. 15, 2004 |     | US 8,007,774 |     | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |     | USA                                           |     | GelrinC     |     | Utility patent            |     | Dec. 31, 2025 |
| Dec. 15, 2004 |     | US 9,120,872 |     | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |     | USA                                           |     | GelrinC     |     | Utility patent            |     | Dec. 31, 2025 |
| Dec. 15, 2004 |     | US 8,858,925 |     | Pegylated fibrinogen precursor molecule                                                                                                |     | USA                                           |     | GelrinC     |     | Utility patent            |     | Jun. 28, 2025 |
| Jun. 21, 2007 |     | EP 1870115   |     | Immediate release compositions for treating tissue damages                                                                             |     | Germany, Spain, France, United Kingdom, Italy |     | GelrinC     |     | Utility patent            |     | Jun. 6, 2027  |
| Apr. 16, 2008 |     | US 9,624,259 |     | Compositions and methods for scaffold formation                                                                                        |     | USA                                           |     | PEG-albumin |     | Utility patent            |     | Aug. 11, 2029 |

<div align='center'>77</div>

| Dec. 16, 2010 
 Dec. 16, 2010 
 Dec. 16, 2010 |     | US 8,846,020  
 EP 2513294    
 CN 102762715  |     | Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof                  
 Scaffolds formed from polymer-protein conjugates, methods of generating same and